FK 506 and Successful Pregnancy in a Patient After Renal Transplantation

By Resch B.   Mache C.J.   Windhager T.   Holzer H.   Leitner G.   Muller W.  

Transplantation Proceedings, Vol. 30, Iss. 1, 1998-02 ,pp. : 163-164

Elsevier

Access to resources Recommend Favorite

FK 506 as Primary Immunosuppressive Therapy in Renal Transplantation

By Preston R.   Ball S.   Cairns T.   Contis J.   Hakim N.   Palmer A.   Papalois V.   Taube D.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1214-1215

Elsevier

Access to resources Recommend Favorite

Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation

By Yu L.   Wang Y.   Fu S.J.   Cheng X.J.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1709-1710

Elsevier

Access to resources Recommend Favorite

Severe neurotoxicity of tacrolimus (FK506) after renal transplantation: two case reports

By Scheel A.K.   Blaschke S.   Schettler V.   Mayer C.   Muller G.A.   Bittermann H.J.   Grunewald R.-W.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3693-3694

Elsevier

Access to resources Recommend Favorite

The beneficial effects of FK 506 on living-related renal transplantation in presensitized recipients

By Miura S.   Okazaki H.   Sato T.   Amada N.   Ohashi Y.   Hashizume E.  

Transplantation Proceedings, Vol. 31, Iss. 5, 1999-08 ,pp. : 1973-1975

Elsevier

Access to resources Recommend Favorite